We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.9B
AUM Growth
+$1.75B
(+7.2%)
Cap. Flow
+$434M
Cap. Flow
% of AUM
1.67%
Top 10 Holdings %
Top 10 Hldgs %
23.48%
Holding
1,080
New
134
Increased
325
Reduced
445
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$189M |
| 2 |
Intel
INTC
|
+$180M |
| 3 |
Amphenol
APH
|
+$132M |
| 4 |
Intuit
INTU
|
+$106M |
| 5 |
Southwest Airlines
LUV
|
+$86.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$221M |
| 2 |
Constellation Energy
CEG
|
+$181M |
| 3 |
Uber
UBER
|
+$169M |
| 4 |
Mastercard
MA
|
+$140M |
| 5 |
Exelon
EXC
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.39% |
| 2 | Financials | 14.25% |
| 3 | Consumer Discretionary | 12.97% |
| 4 | Industrials | 12.61% |
| 5 | Healthcare | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNBR
326
DELISTED
Sleep Number
SNBR
| $9.89M | 0.04% |
539,701
-95,029
| -15% | -$1.24M |
|
327
LegalZoom.com
LZ
$1.39B
| $9.84M | 0.04% |
1,549,093
-129,375
| -8% | -$847K |
|
|
SPTN
328
DELISTED
SpartanNash
SPTN
| $9.83M | 0.04% |
438,465
+441
| +0.1% | +$9.1K |
|
329
Amkor Technology
AMKR
$11.3B
| $9.8M | 0.04% |
320,328
+71,625
| +29% | +$2.44M |
|
|
RYZ
330
Ryerson Holding Corp
RYZ
$1.61B
| $9.56M | 0.04% |
480,341
+31,046
| +7% | +$627K |
|
331
ARS Pharmaceuticals
SPRY
$563M
| $9.47M | 0.04% |
653,048
+288,021
| +79% | +$3.43M |
|
332
Magnolia Oil & Gas
MGY
$5.55B
| $9.42M | 0.04% |
385,942
-820,201
| -68% | -$20.7M |
|
333
Hamilton Insurance Group
HG
$3.7B
| $9.42M | 0.04% |
+487,032
| New | +$8.7M |
|
|
GOGL
334
DELISTED
Golden Ocean Group
GOGL
| $9.29M | 0.04% |
694,290
+168,898
| +32% | +$2.1M |
|
|
BBT
335
Beacon Financial Corp
BBT
$2.51B
| $9.17M | 0.04% |
340,694
+75,476
| +28% | +$1.97M |
|
336
XPO
XPO
$24B
| $9.16M | 0.04% |
85,198
-28,571
| -25% | -$3.2M |
|
|
B
337
DELISTED
Barnes Group Inc.
B
| $9.15M | 0.04% |
226,549
-46,774
| -17% | -$1.84M |
|
338
Thor Industries
THO
$4.13B
| $9.11M | 0.04% |
82,877
+66,897
| +419% | +$6.8M |
|
|
SAGE
339
DELISTED
Sage Therapeutics
SAGE
| $9.1M | 0.04% |
1,260,017
-165,361
| -12% | -$1.51M |
|
340
Playtika
PLTK
$1.51B
| $9.01M | 0.03% |
1,137,595
+142,112
| +14% | +$1.07M |
|
341
Harmony Biosciences
HRMY
$2.07B
| $8.98M | 0.03% |
224,481
-20,845
| -8% | -$732K |
|
|
BASE
342
DELISTED
Couchbase
BASE
| $8.97M | 0.03% |
556,361
-26,424
| -5% | -$457K |
|
343
JPMorgan Chase
JPM
$950B
| $8.96M | 0.03% |
42,511
+5,152
| +14% | +$1.09M |
|
344
Worthington Steel
WS
$1.9B
| $8.95M | 0.03% |
263,087
+68,792
| +35% | +$2.36M |
|
345
Zumiez
ZUMZ
$347M
| $8.87M | 0.03% |
416,274
+123,047
| +42% | +$2.95M |
|
|
PRA
346
DELISTED
ProAssurance
PRA
| $8.84M | 0.03% |
587,901
+1,738
| +0.3% | +$22.2K |
|
347
Live Oak Bancshares
LOB
$1.99B
| $8.78M | 0.03% |
185,309
+83,639
| +82% | +$3.5M |
|
|
HSII
348
DELISTED
Heidrick & Struggles
HSII
| $8.73M | 0.03% |
224,777
+30,998
| +16% | +$1.12M |
|
349
UMB Financial
UMBF
$10.9B
| $8.65M | 0.03% |
82,337
-1,195
| -1% | -$117K |
|
350
Core & Main
CNM
$8.23B
| $8.57M | 0.03% |
193,072
+38,023
| +25% | +$1.82M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2024 Portfolio in Review
As of Q3 2024, Jacobs Levy Equity Management held 1,080 positions worth $25.9B, up 7.2% from $24.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jacobs Levy Equity Management's Q3 2024 filing shows 134 new, 325 increased, 445 reduced and 139 closed positions. Its largest new stake was Lam Research: 962,880 shares worth $78.6M. The largest sale was Fortinet, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2024 buy was Lam Research: 962,880 shares worth $78.6M.
- Jacobs Levy Equity Management added most to Edwards Lifesciences in Q3 2024, an estimated $189M increase.
- Jacobs Levy Equity Management's biggest Q3 2024 reduction was Fortinet, cutting an estimated $221M.
- Jacobs Levy Equity Management fully exited Smartsheet Inc. in Q3 2024, selling an estimated $81.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 23% of its $25.9B portfolio in Q3 2024.
- Jacobs Levy Equity Management opened 134 new positions and closed 139 in Q3 2024.
- Jacobs Levy Equity Management's portfolio value rose 7.2% quarter-over-quarter to $25.9B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2024, filed 14 Nov 2024.